british diabetic association(the) Company Information
Group Structure
View All
Industry
Other human health activities
+1Registered Address
wells lawrence house, 126 back church lane, london, E1 1FH
Website
http://diabetes.org.ukbritish diabetic association(the) Estimated Valuation
Pomanda estimates the enterprise value of BRITISH DIABETIC ASSOCIATION(THE) at £63m based on a Turnover of £42.7m and 1.48x industry multiple (adjusted for size and gross margin).
british diabetic association(the) Estimated Valuation
Pomanda estimates the enterprise value of BRITISH DIABETIC ASSOCIATION(THE) at £0 based on an EBITDA of £-6.4m and a 10.47x industry multiple (adjusted for size and gross margin).
british diabetic association(the) Estimated Valuation
Pomanda estimates the enterprise value of BRITISH DIABETIC ASSOCIATION(THE) at £32.2m based on Net Assets of £13.4m and 2.4x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
British Diabetic Association(the) Overview
British Diabetic Association(the) is a live company located in london, E1 1FH with a Companies House number of 00339181. It operates in the other human health activities sector, SIC Code 86900. Founded in April 1938, it's largest shareholder is unknown. British Diabetic Association(the) is a mature, large sized company, Pomanda has estimated its turnover at £42.7m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
British Diabetic Association(the) Health Check
Pomanda's financial health check has awarded British Diabetic Association(The) a 4 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 5 areas for improvement. Company Health Check FAQs


6 Strong

1 Regular

5 Weak

Size
annual sales of £42.7m, make it larger than the average company (£595.9k)
£42.7m - British Diabetic Association(the)
£595.9k - Industry AVG

Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6.4%)
4% - British Diabetic Association(the)
6.4% - Industry AVG

Production
with a gross margin of 66.3%, this company has a comparable cost of product (66.3%)
66.3% - British Diabetic Association(the)
66.3% - Industry AVG

Profitability
an operating margin of -15.6% make it less profitable than the average company (3.7%)
-15.6% - British Diabetic Association(the)
3.7% - Industry AVG

Employees
with 458 employees, this is above the industry average (14)
458 - British Diabetic Association(the)
14 - Industry AVG

Pay Structure
on an average salary of £47.5k, the company has a higher pay structure (£27.5k)
£47.5k - British Diabetic Association(the)
£27.5k - Industry AVG

Efficiency
resulting in sales per employee of £93.2k, this is more efficient (£52.4k)
£93.2k - British Diabetic Association(the)
£52.4k - Industry AVG

Debtor Days
it gets paid by customers after 2 days, this is earlier than average (17 days)
2 days - British Diabetic Association(the)
17 days - Industry AVG

Creditor Days
its suppliers are paid after 47 days, this is slower than average (25 days)
47 days - British Diabetic Association(the)
25 days - Industry AVG

Stock Days
it holds stock equivalent to 4 days, this is less than average (22 days)
4 days - British Diabetic Association(the)
22 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 8 weeks, this is less cash available to meet short term requirements (122 weeks)
8 weeks - British Diabetic Association(the)
122 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 52.2%, this is a higher level of debt than the average (24.9%)
52.2% - British Diabetic Association(the)
24.9% - Industry AVG
BRITISH DIABETIC ASSOCIATION(THE) financials

British Diabetic Association(The)'s latest turnover from December 2023 is £42.7 million and the company has net assets of £13.4 million. According to their latest financial statements, British Diabetic Association(The) has 458 employees and maintains cash reserves of £2.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 42,700,000 | 42,115,000 | 37,884,000 | 37,655,000 | 38,841,000 | 34,837,000 | 40,642,000 | 36,474,000 | 37,028,000 | 41,808,000 | 38,840,000 | 27,834,000 | 29,526,000 | 29,334,000 | 28,876,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | -6,407,000 | -650,000 | 966,000 | 712,000 | 755,000 | -3,460,000 | 1,757,000 | -3,948,000 | -656,000 | 5,159,000 | 5,309,000 | -1,642,000 | 2,546,000 | 3,002,000 | -1,844,000 |
Tax | |||||||||||||||
Profit After Tax | -6,407,000 | -650,000 | 966,000 | 712,000 | 755,000 | -3,460,000 | 1,757,000 | -3,948,000 | -656,000 | 5,159,000 | 5,309,000 | -1,642,000 | 2,546,000 | 3,002,000 | -1,844,000 |
Dividends Paid | |||||||||||||||
Retained Profit | -6,407,000 | -650,000 | 966,000 | 712,000 | 755,000 | -3,460,000 | 1,757,000 | -3,948,000 | -656,000 | 5,159,000 | 5,309,000 | -1,642,000 | 2,546,000 | 3,002,000 | -1,844,000 |
Employee Costs | 21,740,000 | 18,184,000 | 16,729,000 | 17,367,000 | 16,280,000 | 15,523,000 | 14,990,000 | 15,193,000 | 14,034,000 | 12,855,000 | 11,710,000 | 10,794,000 | 10,219,000 | 9,641,000 | 11,184,000 |
Number Of Employees | 458 | 405 | 399 | 400 | 402 | 386 | 389 | 399 | 381 | 346 | 327 | 307 | 290 | 266 | 295 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 2,024,000 | 1,581,000 | 1,297,000 | 1,360,000 | 1,576,000 | 1,800,000 | 2,173,000 | 2,195,000 | 516,000 | 733,000 | 631,000 | 748,000 | 993,000 | 1,114,000 | 1,571,000 |
Intangible Assets | |||||||||||||||
Investments & Other | 17,163,000 | 19,409,000 | 20,040,000 | 19,340,000 | 21,393,000 | 16,745,000 | 19,526,000 | 21,660,000 | 24,517,000 | 20,479,000 | 5,118,000 | 4,903,000 | 6,499,000 | 7,791,000 | 8,358,000 |
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 19,187,000 | 20,990,000 | 21,337,000 | 20,700,000 | 22,969,000 | 18,545,000 | 21,699,000 | 23,855,000 | 25,033,000 | 21,212,000 | 5,749,000 | 5,651,000 | 7,492,000 | 8,905,000 | 9,929,000 |
Stock & work in progress | 167,000 | 116,000 | 81,000 | 119,000 | 53,000 | 61,000 | 150,000 | 88,000 | 100,000 | 38,000 | 48,000 | 51,000 | 30,000 | 51,000 | 55,000 |
Trade Debtors | 262,000 | 67,000 | 320,000 | 307,000 | 384,000 | 2,601,000 | 4,419,000 | 399,000 | 432,000 | 418,000 | 1,057,000 | 888,000 | 749,000 | 940,000 | 1,035,000 |
Group Debtors | |||||||||||||||
Misc Debtors | 5,981,000 | 3,271,000 | 4,297,000 | 1,752,000 | 3,315,000 | 966,000 | 1,214,000 | 2,866,000 | 3,129,000 | 4,578,000 | 4,695,000 | 1,368,000 | 2,530,000 | 4,242,000 | 2,566,000 |
Cash | 2,453,000 | 7,373,000 | 5,396,000 | 7,338,000 | 3,683,000 | 7,231,000 | 7,467,000 | 5,516,000 | 4,369,000 | 7,804,000 | 17,021,000 | 14,453,000 | 12,636,000 | 7,450,000 | 6,699,000 |
misc current assets | |||||||||||||||
total current assets | 8,863,000 | 10,827,000 | 10,094,000 | 9,516,000 | 7,435,000 | 10,859,000 | 13,250,000 | 8,869,000 | 8,030,000 | 12,838,000 | 22,821,000 | 16,760,000 | 15,945,000 | 12,683,000 | 10,355,000 |
total assets | 28,050,000 | 31,817,000 | 31,431,000 | 30,216,000 | 30,404,000 | 29,404,000 | 34,949,000 | 32,724,000 | 33,063,000 | 34,050,000 | 28,570,000 | 22,411,000 | 23,437,000 | 21,588,000 | 20,284,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 1,871,000 | 1,153,000 | 868,000 | 420,000 | 994,000 | 838,000 | 796,000 | 805,000 | 394,000 | 730,000 | 160,000 | 278,000 | 370,000 | 466,000 | 453,000 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 12,521,000 | 10,617,000 | 9,845,000 | 10,038,000 | 10,383,000 | 10,363,000 | 11,800,000 | 11,903,000 | 9,274,000 | 9,671,000 | 10,488,000 | 8,945,000 | 8,457,000 | 8,407,000 | 9,684,000 |
total current liabilities | 14,392,000 | 11,770,000 | 10,713,000 | 10,458,000 | 11,377,000 | 11,201,000 | 12,596,000 | 12,708,000 | 9,668,000 | 10,401,000 | 10,648,000 | 9,223,000 | 8,827,000 | 8,873,000 | 10,137,000 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | 238,000 | 220,000 | 241,000 | 247,000 | 255,000 | 223,000 | 239,000 | 137,000 | 533,000 | 578,000 | 172,000 | 135,000 | 502,000 | ||
total long term liabilities | 238,000 | 220,000 | 418,000 | 1,993,000 | 1,661,000 | 1,598,000 | 1,832,000 | 2,500,000 | 664,000 | 1,061,000 | 172,000 | 1,354,000 | 2,030,000 | 1,104,000 | 1,942,000 |
total liabilities | 14,630,000 | 11,990,000 | 11,131,000 | 12,451,000 | 13,038,000 | 12,799,000 | 14,428,000 | 15,208,000 | 10,332,000 | 11,462,000 | 10,820,000 | 10,577,000 | 10,857,000 | 9,977,000 | 12,079,000 |
net assets | 13,420,000 | 19,827,000 | 20,300,000 | 17,765,000 | 17,366,000 | 16,605,000 | 20,521,000 | 17,516,000 | 22,731,000 | 22,588,000 | 17,750,000 | 11,834,000 | 12,580,000 | 11,611,000 | 8,205,000 |
total shareholders funds | 13,420,000 | 19,827,000 | 20,300,000 | 17,765,000 | 17,366,000 | 16,605,000 | 20,521,000 | 17,516,000 | 22,731,000 | 22,588,000 | 17,750,000 | 11,834,000 | 12,580,000 | 11,611,000 | 8,205,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 310,000 | 332,000 | 362,000 | 400,000 | 454,000 | 452,000 | 448,000 | 291,000 | 277,000 | 309,000 | 361,000 | 390,000 | 424,000 | 580,000 | 534,000 |
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | 51,000 | 35,000 | -38,000 | 66,000 | -8,000 | -89,000 | 62,000 | -12,000 | 62,000 | -10,000 | -3,000 | 21,000 | -21,000 | -4,000 | 55,000 |
Debtors | 2,905,000 | -1,279,000 | 2,558,000 | -1,640,000 | 132,000 | -2,066,000 | 2,368,000 | -296,000 | -1,435,000 | -756,000 | 3,496,000 | -1,023,000 | -1,903,000 | 1,581,000 | 3,601,000 |
Creditors | 718,000 | 285,000 | 448,000 | -574,000 | 156,000 | 42,000 | -9,000 | 411,000 | -336,000 | 570,000 | -118,000 | -92,000 | -96,000 | 13,000 | 453,000 |
Accruals and Deferred Income | 1,904,000 | 772,000 | -193,000 | -345,000 | 20,000 | -1,437,000 | -103,000 | 2,629,000 | -397,000 | -817,000 | 1,543,000 | 488,000 | 50,000 | -1,277,000 | 9,684,000 |
Deferred Taxes & Provisions | 18,000 | -21,000 | -6,000 | -8,000 | 32,000 | -16,000 | 102,000 | -396,000 | -45,000 | 406,000 | 37,000 | 135,000 | -502,000 | 502,000 | |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | 2,008,000 | 2,425,000 | 1,769,000 | -60,000 | -4,501,000 | 166,000 | 1,575,000 | 808,000 | 774,000 | 3,138,000 | |||||
Change in Investments | -2,246,000 | -631,000 | 700,000 | -2,053,000 | 4,648,000 | -2,781,000 | -2,134,000 | -2,857,000 | 4,038,000 | 15,361,000 | 215,000 | -1,596,000 | -1,292,000 | -567,000 | 8,358,000 |
cash flow from investments | 2,246,000 | 631,000 | -700,000 | 2,053,000 | -4,648,000 | 4,789,000 | 4,559,000 | 4,626,000 | -4,098,000 | -19,862,000 | -49,000 | 3,171,000 | 2,100,000 | 1,341,000 | -5,220,000 |
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | 177,000 | 1,569,000 | -313,000 | 6,000 | -456,000 | 1,248,000 | -1,267,000 | 799,000 | -321,000 | 607,000 | 896,000 | -1,577,000 | 404,000 | 10,049,000 | |
cash and cash equivalents | |||||||||||||||
cash | -4,920,000 | 1,977,000 | -1,942,000 | 3,655,000 | -3,548,000 | -236,000 | 1,951,000 | 1,147,000 | -3,435,000 | -9,217,000 | 2,568,000 | 1,817,000 | 5,186,000 | 751,000 | 6,699,000 |
overdraft | |||||||||||||||
change in cash | -4,920,000 | 1,977,000 | -1,942,000 | 3,655,000 | -3,548,000 | -236,000 | 1,951,000 | 1,147,000 | -3,435,000 | -9,217,000 | 2,568,000 | 1,817,000 | 5,186,000 | 751,000 | 6,699,000 |
british diabetic association(the) Credit Report and Business Information
British Diabetic Association(the) Competitor Analysis

Perform a competitor analysis for british diabetic association(the) by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in E 1 area or any other competitors across 12 key performance metrics.
british diabetic association(the) Ownership
BRITISH DIABETIC ASSOCIATION(THE) group structure
British Diabetic Association(The) has 12 subsidiary companies.
Ultimate parent company
BRITISH DIABETIC ASSOCIATION(THE)
00339181
12 subsidiaries
british diabetic association(the) directors
British Diabetic Association(The) currently has 15 directors. The longest serving directors include Dr Mohamed Hanif (May 2015) and Dr Wendy Thomson (Jul 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Mohamed Hanif | England | 60 years | May 2015 | - | Director |
Dr Wendy Thomson | United Kingdom | 71 years | Jul 2017 | - | Director |
Mrs Melanie Gray | England | 36 years | Jan 2021 | - | Director |
Mr Michael Gibbs | 58 years | Sep 2021 | - | Director | |
Dr Asiya Yunus | England | 44 years | Sep 2021 | - | Director |
Mrs Alexandra Lewis | 53 years | Sep 2021 | - | Director | |
Professor Linda Bauld | England | 54 years | Sep 2021 | - | Director |
Dr Carol Homden | 64 years | Jan 2022 | - | Director | |
Dr Sarah Ali | England | 48 years | May 2022 | - | Director |
Mr Martin Dewhurst | England | 48 years | Mar 2023 | - | Director |
P&L
December 2023turnover
42.7m
+1%
operating profit
-6.7m
0%
gross margin
66.4%
-1.62%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
13.4m
-0.32%
total assets
28.1m
-0.12%
cash
2.5m
-0.67%
net assets
Total assets minus all liabilities
british diabetic association(the) company details
company number
00339181
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
94990 - Activities of other membership organisations n.e.c.
incorporation date
April 1938
age
87
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
CROWE UK LLP
address
wells lawrence house, 126 back church lane, london, E1 1FH
Bank
BARCLAYS BANK PLC
Legal Advisor
-
british diabetic association(the) Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to british diabetic association(the).
british diabetic association(the) Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BRITISH DIABETIC ASSOCIATION(THE). This can take several minutes, an email will notify you when this has completed.
british diabetic association(the) Companies House Filings - See Documents
date | description | view/download |
---|